Balsalazide Disodium Patent Expiration
Balsalazide Disodium is Used for treating mildly to moderately active ulcerative colitis in male patients. It was first introduced by Valeant Pharmaceuticals International
Balsalazide Disodium Patents
Given below is the list of patents protecting Balsalazide Disodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Colazal | US7452872 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | Aug 24, 2026 | Valeant Pharms Intl |
| Colazal |
US7452872 (Pediatric) | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | Feb 24, 2027 | Valeant Pharms Intl |
| Colazal | US7625884 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | Aug 24, 2026 | Valeant Pharms Intl |
| Colazal |
US7625884 (Pediatric) | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | Feb 24, 2027 | Valeant Pharms Intl |
| Giazo | US6197341 | Formulations of balsalazide and its derivatives |
Mar 13, 2018
(Expired) | Valeant Pharms Intl |
| Giazo | US7452872 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | Aug 24, 2026 | Valeant Pharms Intl |
| Giazo | US7625884 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | Aug 24, 2026 | Valeant Pharms Intl |
| Giazo | US8497256 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males | Jun 23, 2031 | Valeant Pharms Intl |
| Giazo | US9192616 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | Aug 02, 2026 | Valeant Pharms Intl |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Balsalazide Disodium Generics
Several generic applications have been filed for Balsalazide Disodium. The first generic version for Balsalazide Disodium was by Hikma Pharmaceuticals Usa Inc and was approved on Dec 28, 2007. And the latest generic version is by Zydus Lifesciences Global Fze and was approved on Jun 8, 2023.
Given below is the list of companies who have filed for Balsalazide Disodium generic.
1. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Balsalazide Disodium. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG | capsule | Prescription | ORAL | AB | Dec 28, 2007 |
2. DASH PHARMS NATCO
Dash Pharmaceuticals Llc A Fully Owned Sub Of Natco Pharma Ltd has filed for 1 generic for Balsalazide Disodium. Given below are the details of the strengths of this generic introduced by Dash Pharms Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG | capsule | Discontinued | ORAL | N/A | Dec 28, 2007 |
3. APOTEX INC
Apotex Inc Etobicoke Site has filed for 1 generic for Balsalazide Disodium. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG | capsule | Prescription | ORAL | AB | Dec 28, 2007 |
4. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Balsalazide Disodium. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.1GM | tablet | Discontinued | ORAL | N/A | Sep 8, 2015 |
5. ZYDUS LIFESCIENCES
Zydus Lifesciences Global Fze has filed for 1 generic for Balsalazide Disodium. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 750MG | capsule | Prescription | ORAL | AB | Jun 8, 2023 |